Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Innovation Council · Running

KLISBio Silk fibroin tissue grafting for peripheral nerve repair

Coordinator
Klisbio SRL, Italy
Runs
1 July 2024 to 30 June 2026
Status
Running
EU funding
€2.5m
Total cost
€3.6m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
101161926

What the project is doing

In the project's own words, from its summary on CORDIS.

Peripheral nerve injury is a major source of disability, impairing muscle movement or normal sensations: 4Mn people annually experience traumatic nerve damage. Current solutions do not always achieve full motor and sensory recovery, leading to loss of sensation/function and pain, with a significant impact to patients lives. With 50% unsuccessful nerve repair procedures, patients require prolonged rehabilitation, and 30% of them experience permanent disability, producing a high socio-economic burden.

KLISBio has developed SILKBridge, a novel cost-effective nerve guide made of silk fibroin for safe and efficient peripheral nerve repair. KLISBios solution, clinically tested with a first in human (FIH) study, supports and protects the regenerating nerve from compressive forces, restoring its function, and reducing pain without patient discomfort. SILKBridge enhances nerve healing without immune rejection nor fibrosis, reducing the costs of rehabilitation and prolonged surgeries.

Topics

Who is involved

OrganisationCityCountryRole
Klisbio SRLBresso (Mi)ItalyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI